TOKYO, JAPAN – July 8, 2022 – Terumo Corporation (TSE: 4543) today unveils “Terumo’s Purpose” to promote joint creation of value with diverse stakeholders. To communicate the message, Terumo has released a new corporate branding video and key visual.
Under the Group Mission of "Contributing to Society through Healthcare", Terumo has contributed to advancing healthcare together with patients, medical professionals, and diverse stakeholders for over 100 years.
Healthcare today is facing major changes due to increase in chronic diseases owing to aging populations and the evolution of new technologies such as genomic medicine, digital technology, and artificial intelligence. Furthermore, as the world continues to face the COVID-19 pandemic, there is increased need for medical systems to be sturdy.
In response to these changes, Terumo defines that Terumo’s Purpose is to contribute to advancing healthcare and enhancing patients' quality of life. Terumo’s Purpose is positioned to be a message that expresses the company’s long-term growth direction based on their Group Mission. By openly communicating this purpose to society, Terumo hopes to create joint value with medical professionals and business partners.
Terumo holds “From Devices to Solutions” as its vision in the 5-Year Growth Strategy(GS26) which started from April 2022. This vision embodies the company’s determination to continue to solve challenges of medical settings amid major paradigm shifts. Terumo will shift focus from “product-centered perspectives” to “customer-centered perspectives” and create valuable solutions together with medical professionals and business partners based on quality, technological capabilities and the innovation brewing backbone that Terumo has cultivated over the years.
Advancing Healthcare and Enhancing Patients’ Quality of Life
Terumo advances healthcare based on reliable quality and technology developed with deep insight of the medical environment.
Through these efforts, we contribute to saving the lives of patients, reducing their difficulties, and helping them lead a better life.
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.